164 related articles for article (PubMed ID: 15482099)
1. Clarithromycin (Biaxin) extended-release tablet: a therapeutic review.
Gotfried MH
Expert Rev Anti Infect Ther; 2003 Jun; 1(1):9-20. PubMed ID: 15482099
[TBL] [Abstract][Full Text] [Related]
2. Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections.
Darkes MJ; Perry CM
Am J Respir Med; 2003; 2(2):175-201. PubMed ID: 14720016
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tolerability of extended-release clarithromycin.
Guay DR; Gustavson LE; Devcich KJ; Zhang J; Cao G; Olson CA
Clin Ther; 2001 Apr; 23(4):566-77. PubMed ID: 11354390
[TBL] [Abstract][Full Text] [Related]
4. Clarithromycin extended-release in community-acquired respiratory tract infections.
Williams KN; Bishai WR
Expert Opin Pharmacother; 2005 Dec; 6(16):2867-76. PubMed ID: 16318437
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis.
Anzueto A; Fisher CL; Busman T; Olson CA
Clin Ther; 2001 Jan; 23(1):72-86. PubMed ID: 11219481
[TBL] [Abstract][Full Text] [Related]
6. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis.
Adler JL; Jannetti W; Schneider D; Zhang J; Palmer R; Notario G
Clin Ther; 2000 Dec; 22(12):1410-20. PubMed ID: 11192133
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
8. A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.
Sokol WN; Sullivan JG; Acampora MD; Busman TA; Notario GF
Clin Ther; 2002 Apr; 24(4):605-15. PubMed ID: 12017405
[TBL] [Abstract][Full Text] [Related]
9. Amoxicillin/clavulanate potassium extended release tablets: a new antimicrobial for the treatment of acute bacterial sinusitis and community-acquired pneumonia.
Benninger MS
Expert Opin Pharmacother; 2003 Oct; 4(10):1839-46. PubMed ID: 14521493
[TBL] [Abstract][Full Text] [Related]
10. A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia.
Gotfried MH; Dattani D; Riffer E; Devcich KJ; Busman TA; Notario GF; Palmer RN
Clin Ther; 2002 May; 24(5):736-51. PubMed ID: 12075942
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of clarithromycin modified release and amoxicillin/clavulanic acid in the treatment of acute exacerbation of chronic bronchitis.
Martinot JB; Carr WD; Cullen S; Heredia Budo JL; Bauer K; MacLeod C; Sanguinetti CM; van Veldhuizen WC;
Adv Ther; 2001; 18(1):1-11. PubMed ID: 11512528
[TBL] [Abstract][Full Text] [Related]
12. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis.
Murray JJ; Solomon E; McCluskey D; Zhang J; Palmer R; Notario G
Clin Ther; 2000 Dec; 22(12):1421-32. PubMed ID: 11192134
[TBL] [Abstract][Full Text] [Related]
13. Overview of newer antimicrobial formulations for overcoming pneumococcal resistance.
Craig WA
Am J Med; 2004 Aug; 117 Suppl 3A():16S-22S. PubMed ID: 15360093
[TBL] [Abstract][Full Text] [Related]
14. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
Nalepa P; Dobryniewska M; Busman T; Notario G
Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
Mathers Dunbar L; Hassman J; Tellier G
Clin Ther; 2004 Jan; 26(1):48-62. PubMed ID: 14996517
[TBL] [Abstract][Full Text] [Related]
16. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Busman TA; Norris S; Notario GF
Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
[TBL] [Abstract][Full Text] [Related]
17. Comparative tolerability, safety and efficacy of tablet formulations of twice-daily clarithromycin 250 mg versus once-daily extended-release clarithromycin 500 mg in pediatric and adolescent patients.
Block SL
Clin Pediatr (Phila); 2006 Sep; 45(7):641-8. PubMed ID: 16928842
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Notario G; Spiller J; Palmer R; Busman T
Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
Neu HC; Chick TW
Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
[TBL] [Abstract][Full Text] [Related]
20. Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults.
Drehobl MA; De Salvo MC; Lewis DE; Breen JD
Chest; 2005 Oct; 128(4):2230-7. PubMed ID: 16236879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
